{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:10:46Z","timestamp":1778785846400,"version":"3.51.4"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST\/INT\/Egypt\/P-02\/2019"],"award-info":[{"award-number":["DST\/INT\/Egypt\/P-02\/2019"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jsbmb.2022.106150","type":"journal-article","created":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T20:05:58Z","timestamp":1656878758000},"page":"106150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Structure-based virtual screening for identification of potential non-steroidal LXR modulators against neurodegenerative conditions"],"prefix":"10.1016","volume":"223","author":[{"given":"Sonam","family":"Deshwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag TK","family":"Baidya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajnish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajat","family":"Sandhir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2022.106150_bib1","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.3389\/fimmu.2020.584303","article-title":"Liver X receptors: Regulators of cholesterol metabolism, inflammation, autoimmunity, and cancer","volume":"11","author":"Bilotta","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1073\/pnas.96.1.266","article-title":"Structural requirements of ligands for the oxysterol liver X receptors LXRa and LXR\u03b2","volume":"96","author":"Janowski","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.jsbmb.2022.106150_bib3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1101\/gad.9.9.1033","article-title":"LXR, a nuclear receptor that defines a distinct retinoid response pathway","volume":"9","author":"Willy","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.jsbmb.2022.106150_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.1995.tb31367.x","article-title":"Ubiquitous recepTor: Structures, immunocytochemical localization, and modulation of gene activation by receptors for retinoic acids and thyroid hormones","volume":"761","author":"Song","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jsbmb.2022.106150_bib5","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1194\/jlr.R075556","article-title":"Therapeutic potential of nuclear receptor agonists in Alzheimer\u2019s disease","volume":"58","author":"Moutinho","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jsbmb.2022.106150_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0378-1119(94)90080-9","article-title":"NER, a new member of the gene family encoding the human steroid hormone nuclear receptor","volume":"147","author":"Shinar","year":"1994","journal-title":"Gene"},{"key":"10.1016\/j.jsbmb.2022.106150_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1097-2765(01)00164-2","article-title":"A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis","volume":"7","author":"Chawla","year":"2001","journal-title":"Mol. Cell."},{"key":"10.1016\/j.jsbmb.2022.106150_bib8","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.3390\/ijms20163858","article-title":"Regulation of brain cholesterol: what role do liver X receptors play in neurodegenerative diseases?","volume":"20","author":"Mouzat","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2022.106150_bib9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ccell.2016.09.008","article-title":"An LXR-cholesterol axis creates a metabolic co-dependency for brain cancers","volume":"30","author":"Villa","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jsbmb.2022.106150_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22010088","article-title":"Ligands of therapeutic utility for the liver X receptors","volume":"22","author":"Komati","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jsbmb.2022.106150_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1751-2980.2011.00554.x","article-title":"Liver X receptors bridge hepatic lipid metabolism and inflammation","volume":"13","author":"Liu","year":"2012","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.jsbmb.2022.106150_bib12","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.3389\/fimmu.2019.01811","article-title":"Liver X receptor alpha is important in maintaining blood-brain barrier function","volume":"10","author":"Wouters","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tem.2016.03.018","article-title":"LXR regulation of brain cholesterol: from development to disease","volume":"27","author":"Courtney","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2022.106150_bib14","doi-asserted-by":"crossref","first-page":"13878","DOI":"10.1073\/pnas.172510899","article-title":"Liver X receptors in the central nervous system: From lipid homeostasis to neuronal degeneration","volume":"99","author":"Wang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.jsbmb.2022.106150_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s12035-013-8461-3","article-title":"LXR agonists: new potential therapeutic drug for neurodegenerative diseases","volume":"48","author":"Xu","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jsbmb.2019.03.003","article-title":"Alterations in cholesterol metabolism as a risk factor for developing Alzheimer\u2019s disease: potential novel targets for treatment","volume":"190","author":"Loera-Valencia","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1749-6632.2012.06513.x","article-title":"The link between altered cholesterol metabolism and Alzheimer\u2019s disease","volume":"1259","author":"Gamba","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jsbmb.2022.106150_bib18","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1007\/s00018-016-2330-y","article-title":"Liver X receptors: from cholesterol regulation to neuroprotection\u2014a new barrier against neurodegeneration in amyotrophic lateral sclerosis?","volume":"73","author":"Mouzat","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jsbmb.2022.106150_bib19","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s12035-017-0453-2","article-title":"Liver X receptor genes variants modulate ALS phenotype","volume":"55","author":"Mouzat","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib20","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/14728222.2011.594043","article-title":"Nuclear receptors as therapeutic targets for Alzheimer\u2019s disease","volume":"15","author":"Mandrekar-Colucci","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jsbmb.2022.106150_bib21","doi-asserted-by":"crossref","first-page":"48508","DOI":"10.1074\/jbc.M209085200","article-title":"Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levels","volume":"277","author":"Fukumoto","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2022.106150_bib22","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2022.106150_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00213","article-title":"The liver X receptor agonist TO901317 ameliorates behavioral deficits in two mouse models of autism","volume":"13","author":"Cai","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jsbmb.2022.106150_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.07.010","article-title":"The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease","volume":"181","author":"Fessler","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jsbmb.2022.106150_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2013.03.008","article-title":"Liver X receptors: emerging therapeutic targets for Alzheimer\u2019s disease","volume":"72","author":"Sodhi","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jsbmb.2022.106150_bib26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.mcn.2007.01.011","article-title":"The LXR agonist TO901317 selectively lowers hippocampal A\u03b242 and improves memory in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"34","author":"Riddell","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jsbmb.2022.106150_bib27","doi-asserted-by":"crossref","first-page":"34144","DOI":"10.1074\/jbc.M110.108100","article-title":"ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden","volume":"285","author":"Donkin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2022.106150_bib28","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/CIRCULATIONAHA.108.782300","article-title":"Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke","volume":"118","author":"Morales","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jsbmb.2022.106150_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174470","article-title":"Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson\u2019s disease","volume":"12","author":"Paterniti","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2022.106150_bib30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.stem.2009.08.019","article-title":"Liver X receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells","volume":"5","author":"Sacchetti","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jsbmb.2022.106150_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jnc.14890","article-title":"Activation of liver X receptor promotes hippocampal neurogenesis and improves long\u2010term cognitive function recovery in acute cerebral ischemia\u2010reperfusion mice","volume":"154","author":"Chen","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jsbmb.2022.106150_bib32","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1172\/JCI42974","article-title":"Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation","volume":"121","author":"Cui","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2022.106150_bib33","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.1073\/pnas.1424951112","article-title":"Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum","volume":"112","author":"Meffre","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jsbmb.2022.106150_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/157489006775244245","article-title":"Non-steroidal LXR agonists; an emerging therapeutic strategy for the treatment of atherosclerosis","volume":"1","author":"Bennett","year":"2006","journal-title":"Recent Pat. Cardiovasc. Drug Disco"},{"key":"10.1016\/j.jsbmb.2022.106150_bib35","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/0091270009335768","article-title":"Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants","volume":"49","author":"Katz","year":"2009","journal-title":"J. Clin. Pharm."},{"key":"10.1016\/j.jsbmb.2022.106150_bib36","first-page":"41","article-title":"Liver X receptors and their agonists: Targeting for cholesterol homeostasis and cardiovascular diseases","volume":"22","author":"Zhiqiang Ma","year":"2017","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib37","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1074\/jbc.M605023200","article-title":"The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR","volume":"282","author":"Cha","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2022.106150_bib38","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1124\/jpet.108.142687","article-title":"Anti-atherosclerotic effects of a novel synthetic tissue-selective steroidal LXR agonist in LDLR\u2212\/\u2212 mice","volume":"327","author":"Peng","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jsbmb.2022.106150_bib39","doi-asserted-by":"crossref","first-page":"11019","DOI":"10.1074\/jbc.M111041200","article-title":"Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by Liver X receptors","volume":"277","author":"Joseph","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2022.106150_bib40","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1194\/jlr.M500116-JLR200","article-title":"Synthetic LXR agonists increase LDL in CETP species","volume":"46","author":"Groot","year":"2005","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.jsbmb.2022.106150_bib41","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1021\/jm0255116","article-title":"Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines","volume":"45","author":"Collins","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2022.106150_bib42","first-page":"488","article-title":"Non-steroidal steroid receptor modulators","volume":"9","author":"Hermkens","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jsbmb.2022.106150_bib43","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jsbmb.2022.106150_bib44","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1080\/07391102.2015.1064830","article-title":"Evaluation of potential flavonoid inhibitors of glyoxalase-I based on virtual screening and in vitro studies","volume":"34","author":"Yadav","year":"2015","journal-title":"J. Biomol. Struct., Dyn."},{"key":"10.1016\/j.jsbmb.2022.106150_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-16033-w","article-title":"Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening","volume":"7","author":"Kumar","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jsbmb.2022.106150_bib46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib47","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jsbmb.2022.106150_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jsbmb.2022.106150_bib49","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jsbmb.2022.106150_bib50","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jsbmb.2022.106150_bib51","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jsbmb.2022.106150_bib52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jmb.2010.04.005","article-title":"X-Ray structures of the LXR\u03b1 LBD in its homodimeric form and implications for heterodimer signaling","volume":"399","author":"Fradera","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib53","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jmb.2003.10.033","article-title":"Crystal structure of the human liver X receptor beta ligand-binding domain in complex with a synthetic agonist","volume":"334","author":"Hoerer","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib54","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00894-020-04508-z","article-title":"PyVibMS: a PyMOL plugin for visualizing vibrations in molecules and solids","volume":"26","author":"Tao","year":"2020","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.jsbmb.2022.106150_bib55","unstructured":"G.M. Morris, D.S. Goodsell, M.E. Pique, R. Huey, S. Forli, W.E. Hart, S. Halliday, R. Belew, A.J. Olson, User guide AutoDock version 4.2 updated for version 4.2.6 automated docking of flexible ligands to flexible receptors, (1991)."},{"key":"10.1016\/j.jsbmb.2022.106150_bib56","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jmgm.2017.08.023","article-title":"IM-UFF: extending the universal force field for interactive molecular modeling","volume":"77","author":"Jaillet","year":"2017","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jsbmb.2022.106150_bib57","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib58","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jsbmb.2022.106150_bib59","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2022.106150_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.jsbmb.2022.106150_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111525","article-title":"Hydroxytyrosol as anti-parkinsonian molecule: Assessment using in-silico and MPTP-induced Parkinson\u2019s disease model","volume":"139","author":"Pathania","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jsbmb.2022.106150_bib62","doi-asserted-by":"crossref","unstructured":"V. Vapnik, The nature of statistical learning theory, 1999.","DOI":"10.1007\/978-1-4757-3264-1"},{"key":"10.1016\/j.jsbmb.2022.106150_bib63","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1021\/ci600312d","article-title":"Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemes","volume":"47","author":"Zhao","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jsbmb.2022.106150_bib64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jsbmb.2022.106150_bib65","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1021\/jm0492002","article-title":"A bioavailability score","volume":"48","author":"Martin","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2022.106150_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mcn.2009.07.013","article-title":"Cholesterol involvement in the pathogenesis of neurodegenerative diseases","volume":"43","author":"Liu","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jsbmb.2022.106150_bib67","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.1007\/s11033-014-3632-5","article-title":"28-Homobrassinolide: a novel oxysterol transactivating LXR gene expression","volume":"41","author":"Premalatha","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jsbmb.2022.106150_bib68","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1093\/emboj\/cdg456","article-title":"Crystal structure of the heterodimeric complex of LXR\u03b1 and RXR\u03b2 ligand-binding domains in a fully agonistic conformation","volume":"22","author":"Svensson","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.jsbmb.2022.106150_bib69","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1021\/acsmedchemlett.5b00170","article-title":"Styrylphenylphthalimides as novel transrepression-selective liver X receptor (LXR) modulators","volume":"6","author":"Nomura","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2022.106150_bib70","doi-asserted-by":"crossref","first-page":"38821","DOI":"10.1074\/jbc.M304842200","article-title":"The three-dimensional structure of the liver X receptor \u03b2 reveals a flexible ligand-binding pocket that can accommodate fundamentally different ligands","volume":"278","author":"F\u00e4rneg\u00e5rdh","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2022.106150_bib71","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1111\/bph.15286","article-title":"Screening for liver X receptor modulators: Where are we and for what use?","volume":"178","author":"Bu\u00f1ay","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib72","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1124\/jpet.115.226738","article-title":"Cinnamamides, novel liver X receptor antagonists that inhibit ligand-induced lipogenesis and fatty liver","volume":"355","author":"Sim","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jsbmb.2022.106150_bib73","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1021\/acs.jmedchem.6b00176","article-title":"Identification and in vivo evaluation of liver X receptor \u03b2-selective agonists for the potential treatment of Alzheimer\u2019s Disease","volume":"59","author":"Stachel","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2022.106150_bib74","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature05449","article-title":"The nuclear receptor LXR is a glucose sensor","volume":"445","author":"Mitro","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2022.106150_bib75","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1194\/jlr.M300135-JLR200","article-title":"The LXR ligand T0901317 induces severe lipogenesis in the db\/db diabetic mouse","volume":"44","author":"Chisholm","year":"2003","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.jsbmb.2022.106150_bib76","doi-asserted-by":"crossref","first-page":"53529","DOI":"10.1371\/journal.pone.0053529","article-title":"The Liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein E","volume":"8","author":"Namjoshi","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jsbmb.2022.106150_bib77","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1523\/JNEUROSCI.6546-10.2011","article-title":"Critical role of astroglial apolipoprotein E and liver X receptor-\u03b1 expression for microglial A\u03b2 phagocytosis","volume":"31","author":"Terwel","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jsbmb.2022.106150_bib78","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1021\/acsnano.0c09159","article-title":"Liver X receptor activation with an intranasal polymer therapeutic prevents cognitive decline without altering lipid levels","volume":"15","author":"Navas Guimaraes","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jsbmb.2022.106150_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-87061-w","article-title":"Vitamin D and lumisterol derivatives can act on liver X receptors (LXRs)","volume":"11","author":"Slominski","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jsbmb.2022.106150_bib80","doi-asserted-by":"crossref","DOI":"10.1007\/s00894-021-04699-z","article-title":"Identifying of selective agonists targeting LXR\u03b2 from terpene compounds of alismatis rhizoma","volume":"27","author":"Lin","year":"2021","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.jsbmb.2022.106150_bib81","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/prot.23209","article-title":"Computational studies of LXR molecular interactions reveal an allosteric communication pathway","volume":"80","author":"Burendahl","year":"2012","journal-title":"Proteins"},{"key":"10.1016\/j.jsbmb.2022.106150_bib82","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.ATV.0000121202.72593.da","article-title":"Role of p160 coactivator complex in the activation of liver X receptor","volume":"24","author":"Huuskonen","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib83","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1210\/me.2002-0399","article-title":"Liver X receptors interact with corepressors to regulate gene expression","volume":"17","author":"Hu","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib84","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-62703-658-0_11","article-title":"Principal component analysis: a method for determining the essential dynamics of proteins","volume":"1084","author":"David","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib85","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1021\/acscentsci.9b00200","article-title":"Explicit characterization of the free energy landscape of pKID-KIX coupled folding and binding","volume":"5","author":"Chong","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jsbmb.2022.106150_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-019-0675-0","article-title":"Structural analysis identifies an escape route from the adverse lipogenic effects of liver X receptor ligands","volume":"2","author":"Belorusova","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib87","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1021\/ci300096c","article-title":"Identification of novel liver X receptor activators by structure-based modeling","volume":"5","author":"von Grafenstein","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jsbmb.2022.106150_bib88","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mce.2011.08.036","article-title":"Selective liver X receptor modulators (SLiMs): what use in human health?","volume":"2","author":"Viennois","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bcp.2018.01.046","article-title":"The tumor-suppressor cholesterol metabolite, dendrogenin A, is a new class of LXR modulator activating lethal autophagy in cancers","volume":"153","author":"Poirot","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2022.106150_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01948-9","article-title":"Dendrogenin A drives LXR to trigger lethal autophagy in cancers","volume":"8","author":"Segala","year":"2017","journal-title":"Nat. Commun."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076022001017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076022001017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T18:24:28Z","timestamp":1778783068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076022001017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":90,"alternative-id":["S0960076022001017"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2022.106150","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based virtual screening for identification of potential non-steroidal LXR modulators against neurodegenerative conditions","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2022.106150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106150"}}